Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Operating Expenses: 2019-2024

Historic Operating Expenses for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Dec 2024 value amounting to $367.1 million.

  • Harmony Biosciences Holdings' Operating Expenses rose 40.18% to $114.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $416.1 million, marking a year-over-year increase of 15.25%. This contributed to the annual value of $367.1 million for FY2024, which is 36.59% up from last year.
  • According to the latest figures from FY2024, Harmony Biosciences Holdings' Operating Expenses is $367.1 million, which was up 36.59% from $268.8 million recorded in FY2023.
  • In the past 5 years, Harmony Biosciences Holdings' Operating Expenses ranged from a high of $367.1 million in FY2024 and a low of $115.0 million during FY2020.
  • Moreover, its 3-year median value for Operating Expenses was $268.8 million (2023), whereas its average is $290.0 million.
  • In the last 5 years, Harmony Biosciences Holdings' Operating Expenses decreased by 23.49% in 2020 and then skyrocketed by 44.21% in 2022.
  • Yearly analysis of 5 years shows Harmony Biosciences Holdings' Operating Expenses stood at $115.0 million in 2020, then skyrocketed by 41.19% to $162.4 million in 2021, then spiked by 44.21% to $234.2 million in 2022, then climbed by 14.76% to $268.8 million in 2023, then spiked by 36.59% to $367.1 million in 2024.